These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 190323)
81. Persistence of protective immunity after inoculation with live varicella vaccine (strain Oka). Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M Biken J; 1984 Sep; 27(2-3):123-8. PubMed ID: 6100049 [No Abstract] [Full Text] [Related]
82. Chickenpox vaccine. Mukerjee AB J Indian Med Assoc; 1976 Jul; 67(1):16-7. PubMed ID: 190324 [No Abstract] [Full Text] [Related]
83. [Trends in research in developing new type of vaccines--aiming at efficacy and safety. Chickenpox vaccine]. Takahashi M Nihon Rinsho; 1987 Oct; 45(10):2403-8. PubMed ID: 2834579 [No Abstract] [Full Text] [Related]
84. [Trial of a varicella vaccine in 100 high-risk children]. Vialatte J; Broyer M; Griscelli C; Gaiffe M; Badillet M; Georges AM Dev Biol Stand; 1982; 52():385-90. PubMed ID: 6299848 [No Abstract] [Full Text] [Related]
85. [Vaccine against varicella-zoster]. Nicodemo AC; Nicodemo EL; Amato Neto V Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(2):55-8. PubMed ID: 2831610 [No Abstract] [Full Text] [Related]
86. Live attenuated varicella vaccine. Gershon AA Pediatr Ann; 1984 Sep; 13(9):653-6. PubMed ID: 6093030 [No Abstract] [Full Text] [Related]
87. Worldwide experience with the Oka-strain live varicella vaccine. Andre FE Postgrad Med J; 1985; 61 Suppl 4():113-20. PubMed ID: 3014468 [TBL] [Abstract][Full Text] [Related]
88. [Varicella vaccination]. Heidl M; Scholz H Padiatr Grenzgeb; 1990; 29(1):31-6. PubMed ID: 2160635 [TBL] [Abstract][Full Text] [Related]
89. The future of varicella vaccine. Plotkin SA; Arbetter AA; Starr SE Postgrad Med J; 1985; 61 Suppl 4():155-62. PubMed ID: 3014474 [TBL] [Abstract][Full Text] [Related]
90. Development of live attenuated varicella vaccine. Gershon AA Proc Assoc Am Physicians; 1995 Oct; 107(3):365-8. PubMed ID: 8608424 [No Abstract] [Full Text] [Related]
91. Varicella vaccine: still at the crossroads. Gershon AA Pediatrics; 1992 Jul; 90(1 Pt 2):144-8. PubMed ID: 1318541 [No Abstract] [Full Text] [Related]
92. Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine. Krause PR; Klinman DM J Pediatr; 1995 Oct; 127(4):518-25. PubMed ID: 7562270 [No Abstract] [Full Text] [Related]
93. Varicella vaccine in immunocompromised patients. Cat LK; Yamauchi NK Ann Pharmacother; 1996 Feb; 30(2):181-4. PubMed ID: 8835053 [No Abstract] [Full Text] [Related]
94. A candidate vaccine for chickenpox. Sarkar JK; Mukherjee KK; Mitra AC; Mukherjee MK; De S J Indian Med Assoc; 1976 Jul; 67(1):1-4. PubMed ID: 190323 [No Abstract] [Full Text] [Related]
95. Varicella vaccine. Gershon AA Isr J Med Sci; 1994; 30(5-6):482-4. PubMed ID: 8034507 [No Abstract] [Full Text] [Related]
96. Varicella vaccine: case studies. Takahashi M; Asano Y; Kamiya H; Baba K Microbiol Sci; 1985 Aug; 2(8):249-54. PubMed ID: 2856380 [TBL] [Abstract][Full Text] [Related]